Video Experimental Relacionado
Updated: Aug 18, 2025
08:27
Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
11.2K
Progreso y desafíos en la meningitis bacteriana: una revisión
1Section of Infectious Diseases, UT Health McGovern Medical School, Houston, Texas.
JAMA
|December 6, 2022
Resumen
La meningitis bacteriana es una grave amenaza para la salud mundial, especialmente en las naciones de bajos ingresos, con una alta mortalidad y daño neurológico a largo plazo. El tratamiento inmediato con antibióticos y la dexametasona son cruciales para controlar esta infección.
Área de la Ciencia:
- Enfermedades infecciosas
- Neurología
- Salud pública
Sus antecedentes:
- La meningitis bacteriana presenta un desafío significativo para la salud mundial, con tasas de incidencia que varían ampliamente según el estatus socioeconómico.
- Las tasas de mortalidad pueden alcanzar el 54% en los países de bajos ingresos, y los sobrevivientes a menudo enfrentan secuelas neurológicas crónicas.
- Los patógenos clave incluyen Streptococcus pneumoniae y Neisseria meningitidis en adultos, y Escherichia coli y Streptococcus agalactiae en recién nacidos.
Conclusiones:
- La meningitis bacteriana requiere atención médica urgente debido a su alta mortalidad y morbilidad.
- El tratamiento empírico inmediato con antibióticos intravenosos es la piedra angular del tratamiento.
- La dexametasona adyuvante juega un papel vital en la mejora de los resultados en pacientes con meningitis bacteriana.
Videos de Conceptos Relacionados
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
29
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
29
01:29Microorganisms in Medicine and Therapeutics
162
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
162
01:31Defense Against Bacterial Pathogens
1.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
01:25Urinary Tract Infection II: Pathophysiology
28
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
28
01:28Pneumonia IV: Management
422
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
422
01:30Pneumonia III: Complications and Assessment
348
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
348